Polyamorphism: a pharmaceutical science perspective
- 1 August 2002
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 54 (8), 1151-1152
- https://doi.org/10.1211/002235702320266343
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- The concept of ‘structure’ in amorphous solids from the perspective of the pharmaceutical sciencesPublished by Royal Society of Chemistry (RSC) ,2002
- The Measurement of Small Quantities of Amorphous Material—Should We Be Considering the Rigid Amorphous Fraction?Pharmaceutical Research, 2001
- What is the True Solubility Advantage for Amorphous Pharmaceuticals?Pharmaceutical Research, 2000
- Crystallization of Indomethacin from the Amorphous State below and above Its Glass Transition TemperatureJournal of Pharmaceutical Sciences, 1994
- Density-driven liquid–liquid phase separation in the system AI2O3–Y2O3Nature, 1994
- ‘Melting ice’ I at 77 K and 10 kbar: a new method of making amorphous solidsNature, 1984
- Polymorphism in Amorphous SiPhysical Review Letters, 1984
- Quantitative Crystallinity Determinations for β-Lactam Antibiotics by Solution Calorimetry: Correlations with StabilityJournal of Pharmaceutical Sciences, 1978
- Glass-Forming Composition Regions and Glass Transition Temperatures for Aqueous Electrolyte SolutionsThe Journal of Chemical Physics, 1970